Skip to main content
  • 42 Accesses

Synonyms

Osteomyelofibrosis; OMF; Chronic idiopathic myelofibrosis; CIMF; Myelofibrosis with myeloid metaplasia; MMM; Agnogenic myeloid metaplasia

Definition and Characteristics

CIMF is an acquired stem-cell disorder, characterized by a secondary, reactive stromal reaction in the bone marrow microenvironment, which is responsible for impaired hematopoesis. In an early hyperproliferative phase proliferative features (thrombocytosis) may be dominant. Later hepatosplenomegaly, cytopenias and extramedullary hematopoesis are prominent features. A small proportion of patients progress to a leukemic transformation [1,2].

Bone marrow fibrosis may be an end-stage feature of another hematological disease (e.g. post-polycythemic (PPMM) or post-thrombocythemic (PTMM) myelofibrosis), sometimes difficult to differentiate from primary IMF.

Prevalence

Estimates of IMF incidence range from 0.5–1.5 new cases/100,000. Given the long survival, prevalence estimates are about 5–10-fold higher.

Molecular and...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tefferi A, Vardiman JW (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization Criteria and point - of - care diagnostic algorithms. Leukemia 22:14–22

    PubMed  CAS  Google Scholar 

  2. Campbell PJ, Green AR (2006) The myeloproliferative disorders. N Engl J Med 355:2452–2466

    PubMed  CAS  Google Scholar 

  3. James C, Ugo V, Le Couédic JP et al. (2005) A unique donal JAK2 mutation leading to constitutive signalling causes polycythacmia vera. Nature 434:1144–1148

    PubMed  CAS  Google Scholar 

  4. Mesa RA, Barosi G, Cervantes F, Reilly JT, Tefferi A (2006) Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options. Best Pract Res Clin Haematol 19:495–517

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag GmbH Berlin Heidelberg

About this entry

Cite this entry

Schuler, U.S. (2009). Myelofibrosis. In: Lang, F. (eds) Encyclopedia of Molecular Mechanisms of Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_1220

Download citation

Publish with us

Policies and ethics